Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
International Journal of MS Care|April 2, 2014
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational StudyBhupendra O Khatri, John F Foley, Jennifer Fink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE studyLudwig Kappos, Eva Havrdova, Gavin Giovannoni, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
VO2max as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trialJohn Wilson, Xiaojun You, Matt Ellis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 10, 2026
APOE-ε4 carriership and dementia risk over 10 years among Asian American and White older adultsYingyan Wu, L Paloma Rojas-Saunero, Yixuan Zhou, et al.
AIDS Patient Care and Stds|September 14, 2019
Improving the Youth HIV Prevention and Care Cascades: Innovative Designs in the Adolescent Trials Network for HIV/AIDS InterventionsSylvie Naar, Michael G Hudgens, Ron Brookmeyer, et al.
Archives of Neurology|July 14, 2010
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-upRichard A Rudick, Jar-Chi Lee, Gary R Cutter, et al.
Cell Reports|May 3, 2019
Comprehensive Profiling of HIV Antibody EvolutionSusan H Eshleman, Oliver Laeyendecker, Kai Kammers, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2023
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxisJan Astermark, Tyler W Buckner, Laurent Frenzel, et al.
Pageof 15